Ishita Drugs & Industries Ltd

INTIMATION ABOUT THE BOOK CLOSURE FOR 33RD ANNUAL GENERAL MEETING (AGM)

Register of Members and Share transfer book of the Company will remain closed from 24.09.2026 to 30.09.2026 (Both days Inc lusive) for the purpose of 33rd Annual General Meeting of the Company.

Corp. Action / Book Closure View filing →

INTIMATION OF E- VOTING AS PER THE REGULATION 44 OF SEBI (LODR) REGULATION, 2015

The E-voting period for ensuing 33rd AGM which is to be held on 30.09.2026 will commence from 27.09.2026 (09:00 a.m. IST) and ends on 29.09.2026 (05:00 p.m. IST) (Both days inclusive).

AGM/EGM / AGM View filing →

NOTICE OF 33RD ANNUAL GENERAL MEETING (AGM) ALONG WITH THE E-VOTING PERIOD

Notice of 33RD AGM of the Company which will be held on wednesday, 30th September, 2026 and E voting period for AGM commence from 27.09.2026 (09:00 a.m. IST) and ends on 29.09.2026 (5:00 p.m. IST)

AGM/EGM / AGM View filing →

Reg. 34 (1) Annual Report.

Annual Report for the Financial Year 2025-26 including Notice of 33rd Annual General Meeting of the Company to be held on 30.09.2026.

Others / Reg. 34 (1) Annual Report View filing →

Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (LODR) Regulations, 2015 For The Quarter Ended 30Th June, 2026.

Ishita Drugs & Industries Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2026 ,inter alia, to consider and approve 1. To consider, approve ....

Board Meeting / Board Meeting View filing →

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Compliance Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th June, 2026 as attached.

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011

Disclosure under regulation 29(2) of SEBI(SAST) Regulations, 2011, received from Ishita Pharmaceuticals, related party of Ishita Drugs and Industries Limited.

Company Update / General View filing →

Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011

Disclosure under regulation 29(2) of SEBI (SAST) Regulations, 2011, received from Ishita Pharmaceuticals, related party of ishita Drugs and Industries Limited.

Company Update / General View filing →